COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,238 Articles (22,733 medRxiv, 8,505 bioRxiv)

Most recent first Previous |  Page 1611: Articles 16101-16110  | Next

Modeling non-pharmaceutical interventions in the COVID-19 pandemic with survey-based simulations
Kaffai, M., Heiberger, R. H.
10.1101/2021.04.16.21255606 — Posted: 2021-04-16
Changes in eating habits and sedentary behavior during the COVID-19 pandemic in adolescents with chronic conditions
Mazzolani, B. C., Smaira, F. I., Astley, C., Iraha, A. Y., Pinto, A. J., Marques, I. G., Amarante, M. C., Rezende, N. S., Sieczkowska, S. M., Franco, T. C., Miranda, L. C. d. A., Lindoso, L., Helito, A. C., Oba, J., Queiroz, L. B., Pereira, R. M. R., Roschel, H., Silva, C. A., Gualano, B.
10.1101/2021.04.16.21255582 — Posted: 2021-04-16
More than a year after the onset of the CoVid-19 pandemic in the UK: lessons learned from a minimalistic model capturing essential features including social awareness and policy making
Duran-Olivencia, M. A., Kalliadasis, S.
10.1101/2021.04.15.21255510 — Posted: 2021-04-16
SARS-CoV-2 Immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021: Implications for vaccination policy
Abu Jabal, K., Ben Amram, H., Beiruti, K., Brimat, I., Abu Saada, A., Bathish, Y., Sussan, C., Zarka, S., Edelstein, M.
10.1101/2021.04.11.21255273 — Posted: 2021-04-16
The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada
Groves, H. E., Piche-Renaud, P.-P., Peci, A., Farrar, D., Buckrell, S., Bancej, C., Sevenhuysen, C., Campigotto, A., Gubbay, J., Morris, S.
10.1101/2021.04.15.21255591 — Posted: 2021-04-16
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
Shi, G., Chiramel, A. I., Majdoul, S., Lai, K. K., Das, S., Beare, P. A., Andresson, T., Best, S. M., Compton, A. A.
10.1101/2021.04.15.440067 — Posted: 2021-04-16
A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model
Peter, A. S., Roth, E., Schulz, S. R., Fraedrich, K., Steinmetz, T., Damm, D., Hauke, M., Richel, E., Mueller-Schmucker, S., Habenicht, K., Eberlein, V., Issmail, L., Uhlig, N., Dolles, S., Gruner, E., Peterhoff, D., Ciesek, S., Hoffmann, M., Pohlmann, S., McKay, P. F., Shattock, R. J., Wolfel, R., Wagner, R., Eichler, J., Schuh, W., Neipel, F., Ensser, A., Mielenz, D., Tenbusch, M., Winkler, T. H., Grunwald, T., Uberla, K., Jack, H.-M.
10.1101/2021.04.16.440101 — Posted: 2021-04-16
Viral neuroinvasion and neurotropism without neuronal damage in the hACE2 mouse model of COVID-19
Seehusen, F., Clark, J. J., Sharma, P., Subramaniam, K., Wunderlin Giuliani, S., Hughes, G., Patterson, E. I., Michael, B. D., Owen, A., Hiscox, J. A., Stewart, J. P., Kipar, A.
10.1101/2021.04.16.440173 — Posted: 2021-04-16
Multiplex Fragment Analysis Identifies SARS-CoV-2 Variants
Clark, A. E., Wang, Z., Cantarel, B. L., Kanchwala, M., Xing, C., Chen, L., Irwin, P., Xu, Y., Oliver, D., Lee, F., Gagan, J. R., Park, J. Y., Filkins, L., Muthukumar, A., Sarode, R., SoRelle, J. A.
10.1101/2021.04.15.21253747 — Posted: 2021-04-16
Randomized, Comparative, Clinical Trial to Evaluate Efficacy and Safety of PNB001 in Moderate COVID-19 Patients
Lattman, E., Bhalerao, P., BL, S., Nargundkar, N., Lattmann, P., Pillai K, S., Balaram, P. N.
10.1101/2021.04.16.21255256 — Posted: 2021-04-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).